Company Logo

RAF-709

Pharmaceutical Information

Updated on Apr 19, 2019

View more like this | Visit SHIRLEY, NY | Contact BOC Smith
RAF-709 is a novel Raf kinase inhibitor used for the treatment of non-small cell lung cancer (NSCLC).
Image for RAF-709 with ID of: 3389655
goodideazs, LLC is not affiliated with the authors of this post nor is it responsible for its content, the accuracy and authenticity of which should be independently verified.